TCRX
Tscan Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.05
-0.08 ▼ -7.08%
🌙 3월 13일 7:38 PM ET (한국 3/14 08:38)
$1.07
+0.02 ▲ +1.90%
| Index | - | P/E | - | EPS (ttm) | -1 | Insider Own | 16.28% | Shs Outstand | 0.05B | Perf Week | -6.25% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 6.84% | Insider Trans | 1.78% | Shs Float | 0.05B | Perf Month | 7.98% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.2 | Inst Own | 51.8% | Short Float | 4.05% | Perf Quarter | 1.94% |
| Income | -0.13B | P/S | 5.79 | EPS this Y | 6.87% | Inst Trans | -6.46% | Short Ratio | 3.49 | Perf Half Y | -43.24% |
| Sales | 0.01B | P/B | 0.49 | EPS next 5Y | 6.88% | ROA | -43.26% | Short Interest | 1.93M | Perf YTD | 5% |
| Book/sh | 2.16 | P/C | 0.39 | EPS past 3/5Y | 28.66% 2.08% | ROE | -71.28% | 52W High | -59.14% ($2.57) | Perf Year | -41.34% |
| Cash/sh | 2.68 | P/FCF | - | Sales past 3/5Y | -8.63% 56.92% | ROIC | -61.77% | 52W Low | 18.99% ($0.88) | Perf 3Y | -58.66% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 12.67% | Gross Margin | 72.25% | Volatility(W/M) | 8.91% 8.03% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.14 | Sales Y/Y TTM | 266.65% | Oper. Margin | -1315.38% | ATR (14) | 0.09 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.41 | EPS Q/Q | 40.34% | Profit Margin | -1256.81% | RSI (14) | 46.82 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.41 | Sales Q/Q | 286.02% | SMA20 | -2.15% ($1.07) | Beta | 0.99 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.76 | Earnings | 3000000 | SMA50 | -2.41% ($1.08) | Rel Volume | 1.18 | Prev Close | $1.13 |
| Employees | 142 | LT Debt/Eq | 0.71 | EPS/Sales Surpr. | 33.41% 5.4% | SMA200 | -28.76% ($1.47) | Avg Volume(3M) | 0.55M | Price | $1.05 |
| IPO | 2021/7/16 | Option/Short | No/Yes | Trades | 1543 | Volume | 650,947 | Change | -7.08% |
뉴스 로딩 중...